FDA official logo
GSRS logo
PFDA official logo

RESLIZUMAB

  • UNII: 35A26E427H
  • Preferred Substance Name: RESLIZUMAB

  • 241473-69-8
  • CEP-38072
  • CINQAIR
  • DCP 835
  • DCP-835
  • IMMUNOGLOBULIN G4 (HUMAN-RAT MONOCLONAL SCH 55700 .GAMMA.4-CHAIN ANTI-HUMAN INTERLEUKIN 5), DISULFIDE WITH HUMAN-RAT MONOCLONAL SCH 55770 LIGHT CHAIN, DIMER
  • MAB HUMAN (IGG4) ANTI P05113 (IL5_HUMAN) (SCH55700)
  • RESLIZUMAB [INN]
  • RESLIZUMAB [MI]
  • RESLIZUMAB [PURPLE BOOK CDER]
  • RESLIZUMAB [USAN]
  • RESLIZUMAB [WHO-DD]
  • SCH55700
  • SCH-55700

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.